Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus
暂无分享,去创建一个
S. Giannini | M. Fusaro | T. Nickolas | G. D’Arrigo | A. Piccoli | F. Fabris | M. Ravera | M. Plebani | G. Tripepi | A. Bellasi | M. Gallieni | A. Giusti | D. Gatti | M. Rossini | G. Brunori | G. Iervasi | M. A. Rizzo | S. Sella | M. C. Mereu | L. Lullo | Andrea Aghi | A. Pitino
[1] D. M. Abd El Motteleb,et al. Vitamin K2 alleviates type 2 diabetes in rats by induction of osteocalcin gene expression. , 2018, Nutrition.
[2] P. Winocour. Diabetes and chronic kidney disease: an increasingly common multi‐morbid disease in need of a paradigm shift in care , 2018, Diabetic medicine : a journal of the British Diabetic Association.
[3] J. Starup-Linde,et al. Diabetes and Abdominal Aortic Calcification—a Systematic Review , 2018, Current Osteoporosis Reports.
[4] N. Suksomboon,et al. Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis , 2017, Diabetes, metabolic syndrome and obesity : targets and therapy.
[5] M. Cohen-Solal,et al. Evaluation of fracture risk in chronic kidney disease , 2017, Journal of Nephrology.
[6] P. Stenvinkel,et al. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis , 2017, Journal of Nephrology.
[7] M. Urashima,et al. Role of vitamin D in diabetes mellitus and chronic kidney disease. , 2016, World journal of diabetes.
[8] A. Santoro,et al. Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients , 2016, Journal of Nephrology.
[9] S. Giannini,et al. Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins , 2016, Endocrine.
[10] S. Giannini,et al. Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. , 2015, Current vascular pharmacology.
[11] The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients , 2014, Clinical chemistry and laboratory medicine.
[12] F. Cantatore,et al. Osteocalcin: Skeletal and extra‐skeletal effects , 2013, Journal of cellular physiology.
[13] R. Nuti,et al. Endocrine Actions of Osteocalcin , 2013, International journal of endocrinology.
[14] J. Goudable,et al. Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. , 2013, The Journal of clinical endocrinology and metabolism.
[15] S. Giannini,et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] H. Choi,et al. Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial , 2011, Diabetes Care.
[17] J. Bacchetta,et al. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] H. Xie,et al. Development of Arterial Calcification in Adiponectin‐Deficient Mice: Adiponectin Regulates Arterial Calcification , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] L. Schurgers,et al. Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] L. Schurgers,et al. The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification , 2008, Journal of Vascular Research.
[21] G. Karsenty,et al. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice , 2008, Proceedings of the National Academy of Sciences.
[22] H. Kraemer,et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.
[23] M. Shearer,et al. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification , 2000, Current opinion in clinical nutrition and metabolic care.
[24] D. E. Grobbee,et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis , 1994, The Lancet.